Spero Therapeutics, Inc.
SPRO
Revenue
371.00k
▲306.00k▲470.77%
3 Months ChangeAssets
110.54M
▼-24.62M▼-18.21%
3 Months ChangeLiabilities
64.42M
▼-5.23M▼-7.51%
3 Months ChangeFree Cash Flow
-23.41M
▼-12.40M▼-112.70%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-29
Form 8-K
ID: 0001193125-24-246627
2024-09-10
Form 8-K
ID: 0001193125-24-216310
2024-08-05
Form 10-Q
ID: 0000950170-24-090782
2024-08-05
Form 8-K
ID: 0001193125-24-193913
2024-06-03
Form 8-K
ID: 0001193125-24-153034
2024-05-15
Form 8-K
ID: 0001193125-24-139364
2024-05-15
Form 10-Q
ID: 0000950170-24-060400
2024-03-29
Form 8-K
ID: 0001193125-24-082060
2024-03-13
Form 8-K
ID: 0001193125-24-066825
2024-02-09
Form 8-K
ID: 0001193125-24-029913